Pay in 4 interest-free payments of $25.00 Learn more
Ships within 48 hours · Estimated delivery Aug 3 - Aug 8
8a-octahydroazulen-1-ol
HO-1 and blocked the phosphorylations of IκB
InChi: InChI=1S/C15H10N2O2/c1-19-9-2-3-10-11-6-7-16-12-4-5-14(18)17(15(11)12)13(10)8-9/h2-8H
the plasma clearance of EGFR-IN-2 is determined to be 104 mL/kg per min with a bioavailability of 19%
can be used to prepare drugs for resisting liver cancer and stomach cancer drugs or auxiliary chemotherapy drugs
Relugolix Catalog No.:M18801-C 8a-octahydroazulen-1-olRelugolix (TAK 385) is a potent, orally active, nonpeptidic gonadotropin releasing hormone (GnRH) antagonist. Relugolix possesses high affinity and potent antagonistic activity for human receptor (binding IC50=0. 33 nM) and monkey receptor (IC50=0. 32 nM) compared with TAK 013 (HY 100209). Relugolix is used for the study of sex hormone dependent diseases, such as including endometriosis, uterine fibroids and prostate cancer et al. Product information